Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancer.
Saved in:
| Title: | Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancer. |
|---|---|
| Authors: | Adeleke S; School of Biomedical Engineering and Imaging Sciences (BMEIS), King's College London, London, UK. olusola.adeleke@kcl.ac.uk., Galante JR; Royal Marsden Hospital NHS Foundation Trust, London, UK., Wang Y; Royal Free London NHS Foundation Trust, London, UK., Azad G; Guy's & St Thomas' NHS Foundation Trust, London, UK., Wan S; Institute of Nuclear Medicine, University College London, London, UK., Haroon A; St Bartholomew's Hospital NHS Foundation Trust, London, UK., Bianchini D; Kent Oncology Centre, Maidstone & Tunbridge Wells Hospitals, Kent, UK., Bomanji J; Institute of Nuclear Medicine, University College London, London, UK., Hofman MS; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Centre Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Young TS; California Institute for Biomedical Research (CALIBR), Scripps Research, La Jolla, CA, USA., Cook GJR; School of Biomedical Engineering and Imaging Sciences (BMEIS), King's College London, London, UK. |
| Source: | Nature reviews. Urology [Nat Rev Urol] 2026 Jun; Vol. 23 (6), pp. 395-416. Date of Electronic Publication: 2025 Nov 10. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500082 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4820 (Electronic) Linking ISSN: 17594812 NLM ISO Abbreviation: Nat Rev Urol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
